Endocarditis caused by Lactobacillus jensenii in an immunocompetent patient

Lactobacilli are Gram-positive rod-shaped bacteria that inhabit the oral cavity, gastrointestinal tract, vagina and nasal cavity. In this report, a rare case of Lactobacillus jensenii endocarditis in a 47-year-old immunocompetent patient is described. Blood cultures and a replaced mitral valve were...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical microbiology 2010-05, Vol.59 (5), p.607-609
Hauptverfasser:	ASSUNTA FRADIANI, Piera, PETRUCCA, Andrea, ASCENZIONI, Fiorentina, DI NUCCI, Giandomenico, TEGGI, Antonella, BILANCINI, Silvia, CIPRIANI, Paola
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - therapeutic use Bacteriology Biological and medical sciences Blood - microbiology DNA, Bacterial - chemistry DNA, Bacterial - genetics DNA, Ribosomal - chemistry DNA, Ribosomal - genetics Endocarditis, Bacterial - diagnosis Endocarditis, Bacterial - microbiology Female Fundamental and applied biological sciences. Psychology Gram-Positive Bacterial Infections - diagnosis Gram-Positive Bacterial Infections - microbiology Humans Infectious diseases Lactobacillus - isolation & purification Medical sciences Meropenem Microbial Sensitivity Tests Microbiology Middle Aged Miscellaneous Mitral Valve - microbiology Molecular Sequence Data Sequence Analysis, DNA Teicoplanin - therapeutic use Thienamycins - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Lactobacilli are Gram-positive rod-shaped bacteria that inhabit the oral cavity, gastrointestinal tract, vagina and nasal cavity. In this report, a rare case of Lactobacillus jensenii endocarditis in a 47-year-old immunocompetent patient is described. Blood cultures and a replaced mitral valve were positive for L. jensenii as assessed by 16S rRNA gene sequencing. Based on susceptibility tests the patient was successfully treated with a mixture of teicoplanin and meropenem antimicrobial therapy.
ISSN:	0022-2615 1473-5644
DOI:	10.1099/jmm.0.017764-0